Skip to main content
webinar register page
Topic
Using Artificial Intelligence to Disentangle Glaucoma Pathogenesis
Description
Primary open-angle glaucoma (POAG) is a disease subtype defined by chronic, progressive, and irreversible retinal ganglion cell (RGC) loss without clinically evident causes for either elevated intraocular pressure (IOP) or optic nerve degeneration. Globally, there are currently 53 million POAG cases, with projections of 80 million cases by 2040. These staggering statistics are a clarion call to find cost-effective strategies for glaucoma prevention and treatment. This talk will provide an overview regarding our approach to leverage artificial intelligence in large cohorts containing a wealth of biomarker and environment data to meet these challenges and reduce ocular morbidity due to glaucoma.
Time
Mar 15, 2022 05:00 PM in
Eastern Time (US and Canada)
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host:
.
×
Share via Email
All fields are required
Your Information
Send to
Message preview
Hi there, You are invited to a Zoom webinar. When: Mar 15, 2022 05:00 PM Eastern Time (US and Canada) Topic: Using Artificial Intelligence to Disentangle Glaucoma Pathogenesis Register in advance for this webinar: https://us06web.zoom.us/webinar/register/WN_SzD-SlsgTy2FxLJaPXmRmg After registering, you will receive a confirmation email containing information about joining the webinar. ---------- Webinar Speakers Louis R. Pasquale, MD Louis R. Pasquale, MD is is the Shelley and Steven Einhorn Distinguished Professor of Ophthalmology and Site Chair of the Department of Ophthalmology at Mount Sinai Hospital. He is Vice Chair of Translational Ophthalmology Research at Mount Sinai Healthcare System. Dr. Pasquale is a member of the PLOS One, Journal of Glaucoma, Ophthalmology Glaucoma, Asia-Pacific Journal of Ophthalmology, and American Journal of Ophthalmology editorial boards. He currently serves as Glaucoma Trustee for ARVO and is a member of the National Institute of Health’s National Advisory Eye Council. An NIH Principal Investigator with continuous support since 2006, his research leverages the rich resources available in the Nurses Health Study, Health Professional Follow-up Study and the Women’s Genome Health Study, and focuses on the discovery of primary prevention strategies in the open-angle glaucomas.
×
Switch Time Zone
Time Zone:
(GMT-11:00) Midway Island, Samoa
(GMT-11:00) Pago Pago
(GMT-10:00) Hawaii
(GMT-8:00) Alaska
(GMT-8:00) Juneau
(GMT-7:00) Vancouver
(GMT-7:00) Pacific Time (US and Canada)
(GMT-7:00) Tijuana
(GMT-7:00) Arizona
(GMT-7:00) Yukon
(GMT-6:00) Edmonton
(GMT-6:00) Mountain Time (US and Canada)
(GMT-6:00) Mazatlan
(GMT-6:00) Saskatchewan
(GMT-6:00) Guatemala
(GMT-6:00) El Salvador
(GMT-6:00) Managua
(GMT-6:00) Costa Rica
(GMT-6:00) Tegucigalpa
(GMT-6:00) Chihuahua
(GMT-5:00) Winnipeg
(GMT-5:00) Central Time (US and Canada)
(GMT-5:00) Mexico City
(GMT-5:00) Panama
(GMT-5:00) Bogota
(GMT-5:00) Lima
(GMT-5:00) Monterrey
(GMT-5:00) Acre
(GMT-4:00) Montreal
(GMT-4:00) Eastern Time (US and Canada)
(GMT-4:00) Indiana (East)
(GMT-4:00) Puerto Rico
(GMT-4:00) Caracas
(GMT-4:00) Santiago
(GMT-4:00) La Paz
(GMT-4:00) Guyana
(GMT-3:00) Halifax
(GMT-3:00) Montevideo
(GMT-3:00) Recife
(GMT-3:00) Buenos Aires, Georgetown
(GMT-3:00) Sao Paulo
(GMT-3:00) Atlantic Time (Canada)
(GMT-2:30) Newfoundland and Labrador
(GMT-2:00) Greenland
(GMT-2:00) Fernando de Noronha
(GMT-1:00) Cape Verde Islands
(GMT+0:00) Azores
(GMT+0:00) Universal Time UTC
(GMT+0:00) Greenwich Mean Time
(GMT+0:00) Reykjavik
(GMT+0:00) Nouakchott
(GMT+1:00) Dublin
(GMT+1:00) London
(GMT+1:00) Lisbon
(GMT+1:00) Casablanca
(GMT+1:00) West Central Africa
(GMT+1:00) Algiers
(GMT+1:00) Tunis
(GMT+2:00) Belgrade, Bratislava, Ljubljana
(GMT+2:00) Sarajevo, Skopje, Zagreb
(GMT+2:00) Oslo
(GMT+2:00) Copenhagen
(GMT+2:00) Brussels
(GMT+2:00) Amsterdam, Berlin, Rome, Stockholm, Vienna
(GMT+2:00) Amsterdam
(GMT+2:00) Rome
(GMT+2:00) Stockholm
(GMT+2:00) Vienna
(GMT+2:00) Luxembourg
(GMT+2:00) Paris
(GMT+2:00) Zurich
(GMT+2:00) Madrid
(GMT+2:00) Harare, Pretoria
(GMT+2:00) Warsaw
(GMT+2:00) Prague Bratislava
(GMT+2:00) Budapest
(GMT+2:00) Tripoli
(GMT+2:00) Cairo
(GMT+2:00) Johannesburg
(GMT+2:00) Khartoum
(GMT+3:00) Helsinki
(GMT+3:00) Nairobi
(GMT+3:00) Sofia
(GMT+3:00) Istanbul
(GMT+3:00) Athens
(GMT+3:00) Bucharest
(GMT+3:00) Nicosia
(GMT+3:00) Beirut
(GMT+3:00) Damascus
(GMT+3:00) Jerusalem
(GMT+3:00) Amman
(GMT+3:00) Moscow
(GMT+3:00) Baghdad
(GMT+3:00) Kuwait
(GMT+3:00) Riyadh
(GMT+3:00) Bahrain
(GMT+3:00) Qatar
(GMT+3:00) Aden
(GMT+3:00) Djibouti
(GMT+3:00) Mogadishu
(GMT+3:00) Kiev
(GMT+3:00) Minsk
(GMT+3:00) Chisinau
(GMT+4:00) Dubai
(GMT+4:00) Muscat
(GMT+4:00) Baku, Tbilisi, Yerevan
(GMT+4:30) Tehran
(GMT+4:30) Kabul
(GMT+5:00) Yekaterinburg
(GMT+5:00) Islamabad, Karachi, Tashkent
(GMT+5:30) India
(GMT+5:30) Mumbai, Kolkata, New Delhi
(GMT+5:30) Colombo
(GMT+5:45) Kathmandu
(GMT+6:00) Almaty
(GMT+6:00) Dacca
(GMT+6:00) Astana, Dhaka
(GMT+6:30) Rangoon
(GMT+7:00) Novosibirsk
(GMT+7:00) Krasnoyarsk
(GMT+7:00) Bangkok
(GMT+7:00) Vietnam
(GMT+7:00) Jakarta
(GMT+8:00) Irkutsk, Ulaanbaatar
(GMT+8:00) Beijing, Shanghai
(GMT+8:00) Hong Kong SAR
(GMT+8:00) Taipei
(GMT+8:00) Kuala Lumpur
(GMT+8:00) Singapore
(GMT+8:00) Perth
(GMT+9:00) Yakutsk
(GMT+9:00) Seoul
(GMT+9:00) Osaka, Sapporo, Tokyo
(GMT+9:30) Darwin
(GMT+9:30) Adelaide
(GMT+10:00) Vladivostok
(GMT+10:00) Guam, Port Moresby
(GMT+10:00) Brisbane
(GMT+10:00) Canberra, Melbourne, Sydney
(GMT+10:00) Hobart
(GMT+10:30) Lord Howe IsIand
(GMT+11:00) Magadan
(GMT+11:00) Solomon Islands
(GMT+11:00) New Caledonia
(GMT+12:00) Kamchatka
(GMT+12:00) Fiji Islands, Marshall Islands
(GMT+12:00) Auckland, Wellington
(GMT+13:00) Independent State of Samoa
×
Continue to PayPal
Click to Continue
×
×
Upcoming Meetings
Would you like to start this meeting?
Would you like to start one of these meetings?
View more...